PDB Short entry for 4F63 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-MAY-12 4F63 TITLE CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE TITLE 2 DOMAIN IN COMPLEX WITH COMPOUND 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 458-765); COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, BFGFR, COMPND 6 BFGF-R-1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONCOGENE C- COMPND 7 FGR; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS KINASE, ATP BINDING, PHOSPHORYLATION, TRANS-MEMBRANE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.A.NORMAN,J.BREED,D.OGG REVDAT 3 13-SEP-23 4F63 1 REMARK SEQADV REVDAT 2 27-JUN-12 4F63 1 JRNL REVDAT 1 06-JUN-12 4F63 0 JRNL AUTH R.A.NORMAN,A.K.SCHOTT,D.M.ANDREWS,J.BREED,K.M.FOOTE, JRNL AUTH 2 A.P.GARNER,D.OGG,J.P.ORME,J.H.PINK,K.ROBERTS,D.A.RUDGE, JRNL AUTH 3 A.P.THOMAS,A.G.LEACH JRNL TITL PROTEIN-LIGAND CRYSTAL STRUCTURES CAN GUIDE THE DESIGN OF JRNL TITL 2 SELECTIVE INHIBITORS OF THE FGFR TYROSINE KINASE. JRNL REF J.MED.CHEM. V. 55 5003 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22612866 JRNL DOI 10.1021/JM3004043 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 3 NUMBER OF REFLECTIONS : 22438 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1214 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.62 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1632 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.2920 REMARK 3 BIN FREE R VALUE SET COUNT : 101 REMARK 3 BIN FREE R VALUE : 0.3280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4229 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 28 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.71000 REMARK 3 B22 (A**2) : 3.56000 REMARK 3 B33 (A**2) : -2.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.98000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.549 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.330 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.241 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 24.806 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.915 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.871 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4376 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4049 ; 0.005 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5922 ; 1.421 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9336 ; 0.812 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 539 ; 6.130 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 173 ;36.489 ;23.584 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 727 ;14.958 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;15.581 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 668 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4771 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 843 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 908 ; 0.226 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3869 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2123 ; 0.187 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2311 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 96 ; 0.177 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 2 ; 0.031 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 7 ; 0.094 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 36 ; 0.208 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2846 ; 0.767 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1101 ; 0.592 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4371 ; 0.964 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1820 ; 2.390 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1551 ; 2.744 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 464 A 762 REMARK 3 RESIDUE RANGE : B 461 B 761 REMARK 3 ORIGIN FOR THE GROUP (A): 57.9454 -0.0619 16.2159 REMARK 3 T TENSOR REMARK 3 T11: 0.0150 T22: -0.0580 REMARK 3 T33: -0.0337 T12: 0.0069 REMARK 3 T13: 0.0052 T23: 0.0183 REMARK 3 L TENSOR REMARK 3 L11: 1.7106 L22: 0.1000 REMARK 3 L33: 0.0661 L12: -0.3454 REMARK 3 L13: 0.0694 L23: 0.0297 REMARK 3 S TENSOR REMARK 3 S11: 0.0943 S12: 0.1336 S13: 0.0211 REMARK 3 S21: -0.0233 S22: -0.0769 S23: 0.0404 REMARK 3 S31: -0.0097 S32: 0.0364 S33: -0.0174 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4F63 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072501. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-DEC-04 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6.25-7.25 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54179 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23652 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 17.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 2.630 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.7600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.59 REMARK 200 R MERGE FOR SHELL (I) : 0.71000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.820 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FGK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16-20% PEG8000, 100 MM PCTP, 100-300 REMARK 280 MM AMMONIUM SULFATE, 25% ETHYLENE GLYCOL, PH 6.25-7.25, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 104.15300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.73850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 104.15300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 28.73850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 GLU A 486 REMARK 465 GLY A 487 REMARK 465 ALA A 488 REMARK 465 PHE A 489 REMARK 465 GLY A 490 REMARK 465 ASP A 501 REMARK 465 LYS A 502 REMARK 465 ASP A 503 REMARK 465 LYS A 504 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 ASN A 763 REMARK 465 GLN A 764 REMARK 465 GLU A 765 REMARK 465 GLY B 457 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 VAL B 460 REMARK 465 PHE B 489 REMARK 465 ASP B 501 REMARK 465 LYS B 502 REMARK 465 ASP B 503 REMARK 465 LYS B 504 REMARK 465 PRO B 578 REMARK 465 PRO B 579 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 GLU B 593 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 465 THR B 657 REMARK 465 THR B 658 REMARK 465 ASN B 659 REMARK 465 SER B 762 REMARK 465 ASN B 763 REMARK 465 GLN B 764 REMARK 465 GLU B 765 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 N CG CD OE1 OE2 REMARK 470 GLU A 467 CG CD OE1 OE2 REMARK 470 LYS A 482 CG CD CE NZ REMARK 470 GLN A 491 CG CD OE1 NE2 REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 SER A 518 OG REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LYS A 523 CG CD CE NZ REMARK 470 LYS A 540 CE NZ REMARK 470 LYS A 542 CD CE NZ REMARK 470 GLU A 592 CG CD OE1 OE2 REMARK 470 GLU A 593 CG CD OE1 OE2 REMARK 470 ARG A 646 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 ARG A 675 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 LYS A 711 CE NZ REMARK 470 LYS A 714 NZ REMARK 470 ASP A 720 CG OD1 OD2 REMARK 470 ASN A 724 CG OD1 ND2 REMARK 470 LYS A 748 CE NZ REMARK 470 SER B 461 OG REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 GLU B 467 CG CD OE1 OE2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 GLU B 486 CG CD OE1 OE2 REMARK 470 GLU B 496 CG CD OE1 OE2 REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 514 CE NZ REMARK 470 LYS B 517 CE NZ REMARK 470 GLU B 522 CD OE1 OE2 REMARK 470 LYS B 523 CE NZ REMARK 470 LYS B 542 CG CD CE NZ REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LYS B 598 CG CD CE NZ REMARK 470 LYS B 618 CD CE NZ REMARK 470 GLU B 633 CG CD OE1 OE2 REMARK 470 LYS B 655 CG CD CE NZ REMARK 470 LYS B 656 CD CE NZ REMARK 470 ARG B 675 CZ NH1 NH2 REMARK 470 GLU B 707 CG CD OE1 OE2 REMARK 470 LYS B 711 CE NZ REMARK 470 LYS B 714 CE NZ REMARK 470 LYS B 721 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O1 EDO A 803 O HOH A 917 2.13 REMARK 500 OE2 GLU A 531 O1 EDO A 802 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 579 C - N - CA ANGL. DEV. = 9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 468 92.59 -166.35 REMARK 500 ASP A 519 -18.36 -40.39 REMARK 500 GLU A 593 110.08 -33.22 REMARK 500 ARG A 622 -22.74 76.01 REMARK 500 HIS A 649 15.22 -68.30 REMARK 500 TYR A 701 75.02 47.99 REMARK 500 ARG B 622 -23.66 73.72 REMARK 500 ASP B 641 19.47 57.70 REMARK 500 ARG B 675 42.94 37.04 REMARK 500 ASN B 724 67.95 64.04 REMARK 500 CYS B 725 119.38 -169.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 519 ALA A 520 -148.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0S7 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0S7 B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 803 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4F64 RELATED DB: PDB REMARK 900 RELATED ID: 4F65 RELATED DB: PDB DBREF 4F63 A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4F63 B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4F63 GLY A 457 UNP P11362 EXPRESSION TAG SEQADV 4F63 ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4F63 SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 4F63 GLY B 457 UNP P11362 EXPRESSION TAG SEQADV 4F63 ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4F63 SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 A 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 B 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET 0S7 A 801 23 HET EDO A 802 4 HET EDO A 803 4 HET 0S7 B 801 23 HET EDO B 802 4 HET EDO B 803 4 HETNAM 0S7 5-BROMO-N~4~-(3-METHYL-1H-PYRAZOL-5-YL)-N~2~-[2- HETNAM 2 0S7 (PYRIDIN-3-YL)ETHYL]PYRIMIDINE-2,4-DIAMINE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 0S7 2(C15 H16 BR N7) FORMUL 4 EDO 4(C2 H6 O2) FORMUL 9 HOH *28(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 THR A 521 GLY A 539 1 19 HELIX 3 3 ASN A 568 ARG A 576 1 9 HELIX 4 4 SER A 596 LYS A 617 1 22 HELIX 5 5 ALA A 625 ARG A 627 5 3 HELIX 6 6 ASP A 647 ILE A 651 5 5 HELIX 7 7 LEU A 662 MET A 667 5 6 HELIX 8 8 ALA A 668 ARG A 675 1 8 HELIX 9 9 THR A 678 THR A 695 1 18 HELIX 10 10 PRO A 705 GLU A 715 1 11 HELIX 11 11 THR A 726 TRP A 737 1 12 HELIX 12 12 VAL A 740 ARG A 744 5 5 HELIX 13 13 THR A 746 THR A 761 1 16 HELIX 14 14 PRO B 474 ASP B 476 5 3 HELIX 15 15 THR B 521 GLY B 539 1 19 HELIX 16 16 ASN B 568 ALA B 575 1 8 HELIX 17 17 SER B 596 LYS B 617 1 22 HELIX 18 18 ALA B 625 ARG B 627 5 3 HELIX 19 19 LEU B 662 MET B 667 5 6 HELIX 20 20 ALA B 668 ARG B 675 1 8 HELIX 21 21 THR B 678 THR B 695 1 18 HELIX 22 22 PRO B 705 GLU B 715 1 11 HELIX 23 23 THR B 726 TRP B 737 1 12 HELIX 24 24 VAL B 740 ARG B 744 5 5 HELIX 25 25 THR B 746 ALA B 759 1 14 SHEET 1 A 5 LEU A 478 PRO A 483 0 SHEET 2 A 5 VAL A 492 ILE A 498 -1 O GLU A 496 N VAL A 479 SHEET 3 A 5 VAL A 508 LYS A 514 -1 O VAL A 511 N ALA A 495 SHEET 4 A 5 TYR A 558 GLU A 562 -1 O VAL A 559 N LYS A 514 SHEET 5 A 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 B 2 VAL A 629 VAL A 631 0 SHEET 2 B 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 C 5 LEU B 478 GLU B 486 0 SHEET 2 C 5 GLN B 491 ILE B 498 -1 O LEU B 494 N LYS B 482 SHEET 3 C 5 VAL B 508 MET B 515 -1 O THR B 509 N ALA B 497 SHEET 4 C 5 TYR B 558 GLU B 562 -1 O VAL B 561 N ALA B 512 SHEET 5 C 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 D 2 VAL B 629 VAL B 631 0 SHEET 2 D 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 SITE 1 AC1 12 LEU A 484 GLY A 485 VAL A 492 ALA A 512 SITE 2 AC1 12 VAL A 561 GLU A 562 TYR A 563 ALA A 564 SITE 3 AC1 12 SER A 565 GLY A 567 ASP A 641 HOH A 918 SITE 1 AC2 4 GLU A 531 MET A 535 ASP A 641 GLY A 643 SITE 1 AC3 6 TRP A 684 TYR A 701 ARG A 718 MET A 719 SITE 2 AC3 6 TRP A 737 HOH A 917 SITE 1 AC4 13 LEU B 484 ALA B 512 VAL B 561 GLU B 562 SITE 2 AC4 13 TYR B 563 ALA B 564 SER B 565 GLY B 567 SITE 3 AC4 13 ARG B 627 ASN B 628 LEU B 630 ALA B 640 SITE 4 AC4 13 ASP B 641 SITE 1 AC5 4 GLU B 531 ASP B 641 PHE B 642 GLY B 643 SITE 1 AC6 7 TRP B 684 TYR B 701 LEU B 713 HIS B 717 SITE 2 AC6 7 ARG B 718 MET B 719 TRP B 737 CRYST1 208.306 57.477 65.452 90.00 107.42 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004801 0.000000 0.001506 0.00000 SCALE2 0.000000 0.017398 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016013 0.00000